People with Angelman syndrome are generally expected to have a near-normal life expectancy. The oldest documented individual in medical literature lived to 83 years old. While the condition does carry specific health risks that require lifelong management, many people with Angelman syndrome live well into adulthood and beyond with appropriate care and supervision.
What the Data Actually Shows
The statement “near-normal life expectancy” appears consistently across medical references, but it comes with important context. A large study of 95 adults with Angelman syndrome found that about half were between 18 and 29 years old, roughly a quarter were in their 30s, and about 16% were in their 40s. A smaller number were in their 50s and 60s, and the three oldest individuals in that group were 63, 69, and 83, all women.
These numbers don’t mean most people with Angelman syndrome die young. The age distribution partly reflects that Angelman syndrome wasn’t reliably diagnosed until the late 1980s and 1990s, so older adults with the condition may simply have never received a formal diagnosis. Still, the data makes clear that survival into middle age and beyond is realistic, particularly when health complications are well managed.
Leading Causes of Death by Age
A community-sourced study tracking deaths in Angelman syndrome from 1979 to 2022 identified the primary causes of mortality across different life stages. The patterns shift significantly with age, which matters for families planning long-term care.
In young children (ages 1 to 5), seizures and accidents were the most common causes of death. For school-aged children (6 to 12), accidents became the leading cause, with drowning accounting for the majority. In adolescents (13 to 18), sudden unexpected death in sleep and pneumonia were the top concerns, while seizure-related deaths dropped to zero in that age range.
For young adults aged 19 to 29, respiratory illness and pneumonia became the dominant cause of death. In adults over 30, cancer emerged as the leading cause, followed by pneumonia. Across all ages combined, respiratory illness was the number one cause of death, followed by accidents and seizures. The fourth most common cause, unexpected death during sleep, had not been widely recognized before this study. Because roughly 91% of people with Angelman syndrome have epilepsy, some of these sleep-related deaths may be linked to a known epilepsy complication called SUDEP (sudden unexpected death in epilepsy).
Why Respiratory Illness Is the Biggest Risk
Many people with Angelman syndrome have difficulty coordinating swallowing, which increases the risk of food or liquid entering the lungs. This is called aspiration, and over time it can lead to recurring bouts of pneumonia. The risk tends to grow with age as muscle tone changes and mobility decreases. Aspiration pneumonia was the single most frequent cause of death in young adults with the condition, and it remained a leading cause throughout adulthood. Managing swallowing difficulties, monitoring for signs of aspiration, and staying current on vaccinations are practical steps that can reduce this risk over a lifetime.
Water Safety and Accident Prevention
Accidents are the second leading cause of death overall in Angelman syndrome, and drowning is by far the most common type. About 68% of people with the condition have a strong fascination with water. Combined with poor coordination, low muscle tone, seizure risk, and an inability to call for help verbally, even shallow water poses a serious danger. One documented case involved a child who drowned in a backyard inflatable wading pool just 56 centimeters (about 22 inches) deep after leaving the house unnoticed.
Close supervision around any water, including bathtubs and small pools, is critical at every age. Secure doors and window locks can help prevent elopement, which is a known behavior in Angelman syndrome where the person wanders away from caregivers.
Health Challenges That Increase With Age
Several health issues become more common or more severe as people with Angelman syndrome get older, and managing these directly affects quality of life and longevity.
Scoliosis affects about 10% of children with the condition, but by adulthood the rate climbs to around 50%. About a quarter of those diagnosed with scoliosis eventually need surgery, with men disproportionately affected. Severe scoliosis can restrict breathing and reduce mobility, which compounds other health risks.
Obesity affects roughly 32% of adults with Angelman syndrome, with women at higher risk. Excess weight worsens mobility problems, increases strain on the spine, and can complicate seizure management and overall health. Mobility itself is a complex issue: it depends on the interplay between coordination difficulties, muscle tone changes, scoliosis progression, bone density, and weight. Some adults who walked independently as children may lose that ability over time.
Other ongoing concerns in adulthood include seizure management, sleep disturbances, gastroesophageal reflux, constipation, dental problems, anxiety, and bone density loss. None of these are individually life-threatening in most cases, but together they require consistent, coordinated medical care.
How Genetic Type Affects Severity
Angelman syndrome results from the loss of function of a specific gene on chromosome 15 that is normally inherited from the mother. There are four main ways this can happen, and the genetic mechanism influences how severe symptoms tend to be.
The most common cause, accounting for about 70% of cases, is a deletion of a segment of chromosome 15. People with deletions generally have the most severe symptoms, including more frequent seizures, greater speech limitations, and higher rates of microcephaly. Larger deletions that extend closer to certain chromosomal landmarks tend to be associated with a higher prevalence of epilepsy and movement difficulties.
People whose condition results from inheriting two copies of chromosome 15 from their father (called uniparental disomy, about 2 to 7% of cases) or from imprinting defects (3 to 5%) typically have milder symptoms overall. Those with a direct mutation in the gene itself (about 10% of cases) often have the mildest presentation, with development scores closer to typical ranges. While no study has directly mapped these subtypes to specific life expectancy figures, milder symptom profiles generally mean fewer medical complications over a lifetime.